Ποιοι Είμαστε

About this report

 

In March 2025, BioInnovation Greece convened key stakeholders from academia, government, venture capital, and entrepreneurship to shape a national strategy for advancing Greece’s biotech sector. At the center of this effort is the BioSTART Program, an integrated initiative combining pre-seed funding, expert mentorship, and strategic guidance to turn early-stage research into investable biotech ventures. As Greece sharpens its focus on life sciences and healthcare innovation, BioSTART is poised to play a catalytic role in accelerating commercialization, fostering translational science, and strengthening Greece’s global position in biotechnology.

 

This report outlines the core insights and priorities from the strategy meeting with key stakeholders and outlines a coordinated path forward for building a competitive, resilient biotech ecosystem.